Aberdare ventures ii lp - by aberdare ii annex fund l p investment history in Enteromedics inc

Filed on 2009-02-25 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-09-011436.txt Sec File: edgar/data/1352036/0001209191-09-011436-index.htm

2009-02-24 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 618557 shares at $0.125 remaining shares owned 618557

Common Stock Warrantright To Buy Enteromedics Inc Etrm exercise date 2009-08-24 exercise price 1.38 has valueitem expiration due date 2013-02-24 underlying security shares 618557 underlying security title Common Stock

f1 the securities are owned by aberdare ii annex fund, l.p. ("aberdare annex ii"), which is under common control with aberdare ventures ii, l.p. ("aberdare ii") and aberdare ventures ii (bermuda), l.p. ("aberdare ii bermuda"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the securities owned by aberdare annex ii, and may be deemed to own beneficially the securities held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. aberdare gp ii disclaims beneficial ownership of the securities reported herein, except to the extent of its proportionate pecuniary interest therein. paul h. klingenstein ("klingenstein ") is a manager of aberdare gp ii and has voting and dispositive power over the securities held by aberdare annex ii. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2009-02-25 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-09-011436.txt Sec File: edgar/data/1352036/0001209191-09-011436-index.htm

2009-02-24 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 1237113 shares at $1.15 remaining shares owned 1720467

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f1 the securities are owned by aberdare ii annex fund, l.p. ("aberdare annex ii"), which is under common control with aberdare ventures ii, l.p. ("aberdare ii") and aberdare ventures ii (bermuda), l.p. ("aberdare ii bermuda"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the securities owned by aberdare annex ii, and may be deemed to own beneficially the securities held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. aberdare gp ii disclaims beneficial ownership of the securities reported herein, except to the extent of its proportionate pecuniary interest therein. paul h. klingenstein ("klingenstein ") is a manager of aberdare gp ii and has voting and dispositive power over the securities held by aberdare annex ii. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2009-02-25 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-09-011436.txt Sec File: edgar/data/1352036/0001209191-09-011436-index.htm

2009-02-24 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc remaining shares owned 29702

Common Stock Enteromedics Inc Etrm

f3 the securities are owned by aberdare ii bermuda, which is under common control with aberdare annex ii and aberdare ii. aberdare gp ii serves as the sole general partner of aberdare ii bermuda, and has sole voting and investment control over the securities owned by aberdare ii bermuda, and may be deemed to own beneficially the securities held by aberdare ii bermuda. aberdare gp ii however owns no securities of the issuer directly. aberdare gp ii disclaims beneficial ownership of the securities reported herein, except to the extent of its proportionate pecuniary interest therein. klingenstein is a manager of aberdare gp ii and has voting and dispositive power over the securities held by aberdare ii bermuda. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2009-02-25 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-09-011436.txt Sec File: edgar/data/1352036/0001209191-09-011436-index.htm

2009-02-24 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc remaining shares owned 1431388

Common Stock Enteromedics Inc Etrm

f2 the securities are owned by aberdare ii, which is under common control with aberdare annex ii and aberdare ii bermuda. aberdare gp ii serves as the sole general partner of aberdare ii, and has sole voting and investment control over the securities owned by aberdare ii, and may be deemed to own beneficially the securities held by aberdare ii. aberdare gp ii however owns no securities of the issuer directly. aberdare gp ii disclaims beneficial ownership of the securities reported herein, except to the extent of its proportionate pecuniary interest therein. klingenstein is a manager of aberdare gp ii and has voting and dispositive power over the securities held by aberdare ii. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-06-03 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-034777.txt Sec File: edgar/data/1352036/0001209191-08-034777-index.htm

2008-06-02 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 40000 shares at $4.50 remaining shares owned 483354

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 the shares are owned by aberdare annex ii, which is under common control with aberdare ii. aberdare gp ii serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the shares owned by aberdare annex ii, and may be deemed to own beneficially the shares held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. klingenstein is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare annex ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-06-03 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-034777.txt Sec File: edgar/data/1352036/0001209191-08-034777-index.htm

2008-06-02 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 40000 shares at $4.50 remaining shares owned 1431388

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f1 the shares are owned by aberdare ventures ii, l.p. ("aberdare ii"), which is under common control with aberdare ii annex fund, l.p. ("aberdare annex ii"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare ii, and has sole voting and investment control over the shares owned by aberdare ii, and may be deemed to own beneficially the shares held by aberdare ii. aberdare gp ii however owns no securities of the issuer directly. paul h. klingenstein ("klingenstein") is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-06-03 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-034777.txt Sec File: edgar/data/1352036/0001209191-08-034777-index.htm

2008-05-29 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 6100 shares at $4.50 remaining shares owned 443354

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 the shares are owned by aberdare annex ii, which is under common control with aberdare ii. aberdare gp ii serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the shares owned by aberdare annex ii, and may be deemed to own beneficially the shares held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. klingenstein is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare annex ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-06-03 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-034777.txt Sec File: edgar/data/1352036/0001209191-08-034777-index.htm

2008-05-29 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 6100 shares at $4.50 remaining shares owned 1391388

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f1 the shares are owned by aberdare ventures ii, l.p. ("aberdare ii"), which is under common control with aberdare ii annex fund, l.p. ("aberdare annex ii"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare ii, and has sole voting and investment control over the shares owned by aberdare ii, and may be deemed to own beneficially the shares held by aberdare ii. aberdare gp ii however owns no securities of the issuer directly. paul h. klingenstein ("klingenstein") is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-05-28 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-033573.txt Sec File: edgar/data/1352036/0001209191-08-033573-index.htm

2008-05-23 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 25000 shares at $4.50 remaining shares owned 437254

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 the shares are owned by aberdare annex ii, which is under common control with aberdare ii. aberdare gp ii serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the shares owned by aberdare annex ii, and may be deemed to own beneficially the shares held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. klingenstein is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare annex ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-05-28 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-033573.txt Sec File: edgar/data/1352036/0001209191-08-033573-index.htm

2008-05-23 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 25000 shares at $4.50 remaining shares owned 1385288

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f1 the shares are owned by aberdare ventures ii, l.p. ("aberdare ii"), which is under common control with aberdare ii annex fund, l.p. ("aberdare annex ii"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare ii, and has sole voting and investment control over the shares owned by aberdare ii, and may be deemed to own beneficially the shares held by aberdare ii. aberdare gp ii however owns no securities of the issuer directly. paul h. klingenstein ("klingenstein") is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-05-21 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-032230.txt Sec File: edgar/data/1352036/0001209191-08-032230-index.htm

2008-05-20 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 15000 shares at $4.75 remaining shares owned 412254

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 the shares are owned by aberdare annex ii, which is under common control with aberdare ii. aberdare gp ii serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the shares owned by aberdare annex ii, and may be deemed to own beneficially the shares held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. klingenstein is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare annex ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-05-21 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-032230.txt Sec File: edgar/data/1352036/0001209191-08-032230-index.htm

2008-05-19 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 35000 shares at $4.78 remaining shares owned 397254

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 the shares are owned by aberdare annex ii, which is under common control with aberdare ii. aberdare gp ii serves as the sole general partner of aberdare annex ii, and has sole voting and investment control over the shares owned by aberdare annex ii, and may be deemed to own beneficially the shares held by aberdare annex ii. aberdare gp ii however owns no securities of the issuer directly. klingenstein is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare annex ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-05-21 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-032230.txt Sec File: edgar/data/1352036/0001209191-08-032230-index.htm

2008-05-20 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 15000 shares at $4.75 remaining shares owned 1360288

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f1 the shares are owned by aberdare ventures ii, l.p. ("aberdare ii"), which is under common control with aberdare ii annex fund, l.p. ("aberdare annex ii"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare ii, and has sole voting and investment control over the shares owned by aberdare ii, and may be deemed to own beneficially the shares held by aberdare ii. aberdare gp ii however owns no securities of the issuer directly. paul h. klingenstein ("klingenstein") is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.


Filed on 2008-05-21 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001209191-08-032230.txt Sec File: edgar/data/1352036/0001209191-08-032230-index.htm

2008-05-19 Aberdare Ventures Ii Lp (CIK 1418079) through By Aberdare Ii Annex Fund L P

Invested in Enteromedics Inc bought 35000 shares at $4.78 remaining shares owned 1345288

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f1 the shares are owned by aberdare ventures ii, l.p. ("aberdare ii"), which is under common control with aberdare ii annex fund, l.p. ("aberdare annex ii"). aberdare gp ii, l.l.c. ("aberdare gp ii") serves as the sole general partner of aberdare ii, and has sole voting and investment control over the shares owned by aberdare ii, and may be deemed to own beneficially the shares held by aberdare ii. aberdare gp ii however owns no securities of the issuer directly. paul h. klingenstein ("klingenstein") is the manager of aberdare gp ii and has voting and dispositive power over the shares held by aberdare ii. klingenstein disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. klingenstein is a director of the issuer and, accordingly, files separate section 16 reports.